Calidi Biotherapeutics annual total assets
2021
2022
2023
2024
2025
Calidi Biotherapeutics Total Assets Growth & History (CLDI)
Calidi Biotherapeutics's total assets was $8.9M for fiscal 2025.
View full Calidi Biotherapeutics company overviewCalidi Biotherapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.9M | −$5.3M | −37.55% |
| 2024 | 2024-12-31 | $14.2M | $4.2M | +41.55% |
| 2023 | 2023-12-31 | $10.0M | $7.4M | +285.79% |
| 2022 | 2022-12-31 | $2.6M | −$229.2M | −98.88% |
| 2021 | 2021-12-31 | $231.8M | — | — |
Calidi Biotherapeutics quarterly total assets
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7.2M | −$2.1M | −22.96% |
| Q1 2026 | 2026-03-31 | $9.6M | −$5.5M | −36.33% |
| Q4 2025 | 2025-12-31 | $8.9M | −$5.3M | −37.55% |
| Q3 2025 | 2025-09-30 | $14.0M | $7.4M | +110.74% |
| Q2 2025 | 2025-06-30 | $9.4M | $2.9M | +45.41% |
| Q1 2025 | 2025-03-31 | $15.1M | $7.7M | +103.43% |
| Q4 2024 | 2024-12-31 | $14.2M | $4.2M | +41.55% |
| Q3 2024 | 2024-09-30 | $6.7M | −$11.9M | −64.18% |
| Q2 2024 | 2024-06-30 | $6.4M | −$37.6M | −85.39% |
| Q1 2024 | 2024-03-31 | $7.4M | −$35.8M | −82.85% |
| Q4 2023 | 2023-12-31 | $10.0M | $7.4M | +285.79% |
| Q3 2023 | 2023-09-30 | $18.6M | −$23.6M | −55.91% |
| Q2 2023 | 2023-06-30 | $44.0M | −$187.0M | −80.95% |
| Q1 2023 | 2023-03-31 | $43.2M | −$188.1M | −81.33% |
| Q4 2022 | 2022-12-31 | $2.6M | −$229.2M | −98.88% |
| Q3 2022 | 2022-09-30 | $42.2M | −$189.8M | −81.83% |
| Q2 2022 | 2022-06-30 | $231.0M | — | — |
| Q1 2022 | 2022-03-31 | $231.2M | — | — |
| Q4 2021 | 2021-12-31 | $231.8M | — | — |
| Q3 2021 | 2021-09-30 | $232.0M | — | — |
Calidi Biotherapeutics total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Calidi Biotherapeutics's total assets decreased from $231.8M to $8.9M, a change of −$222.9M. The latest reported quarter, Q2 2026, shows $7.2M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Calidi Biotherapeutics source filings ↗